- Home
- ACIU vs BBCP Comparison
ACIU vs BBCP Comparison
Compare ACIU & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | BBCP |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 333.0M |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ACIU | BBCP |
|---|---|---|
| Price | $3.14 | $6.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $10.00 | $7.50 |
| AVG Volume (30 Days) | ★ 1.3M | 110.1K |
| Earning Date | 11-04-2025 | 01-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $5,482,957.00 | ★ $395,562,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $738.95 | $1.28 |
| P/E Ratio | ★ N/A | $42.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $4.78 |
| 52 Week High | $4.00 | $9.68 |
Technical Indicators
Market Signals| Indicator | ACIU | BBCP |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 66.46 |
| Support Level | $2.54 | $6.29 |
| Resistance Level | $2.99 | $6.92 |
| Average True Range (ATR) | 0.29 | 0.32 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 50.40 | 98.18 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.